Difference between revisions of "Minutes - Medication WG 2024-03-26"
From Health Level 7 Belgium Wiki
KarlienErauw (talk | contribs) |
KarlienErauw (talk | contribs) |
||
| Line 51: | Line 51: | ||
::* we look at the scheme on page 7 of the business rules V.018FR | ::* we look at the scheme on page 7 of the business rules V.018FR | ||
::::* do we need a relationship between the medication line with the careplan, as set by the BIHR project | ::::* do we need a relationship between the medication line with the careplan, as set by the BIHR project | ||
| − | + | ::::* we agree that this is not crucial for the publication so we move ahead ; however it needs to be added to the business rules | |
| − | |||
| − | :: | ||
| − | ::* | ||
| − | |||
| − | |||
| − | |||
'''* Action items:''' | '''* Action items:''' | ||
::* review medication line will be presented to the FHIR validation group in order to move to publication | ::* review medication line will be presented to the FHIR validation group in order to move to publication | ||
| − | + | ::* review business rules | |
| − | ::* review | ||
| − | |||
'''Next meeting: 16 April at 11AM''' | '''Next meeting: 16 April at 11AM''' | ||
Revision as of 15:00, 26 March 2024
Attendees
- Annemieke Vergauwe
- Annabel Dompas
- Benoit Van Houtte
- Hans De Keersmaecker
- Jan Lenie
- Jens Penny
- José Costa Teixeira
- Karlien Erauw
- Philippe Baise
- Lodewijk Sioen
- Marcelo Romero-Cors
- Tom Henkens
- Walter Bollaert
Excused/Not present
- Anne Nerenhausen
- Bart Decuypere
- Bart Rondou
- Dieter Sauvillers
- Félix De Tavernier
- Hanne Vuegen
- Jean-Michel Polfliet
- Lars Vanreppelen
- Nathan Peeters
- Richard Francken
- Marc Buckens
- Nick Hermans
- Nils Devos
- Pablo Christiaens
- Stephane Bouillon
- Thomas Van Langendonck
- Tom De Backer
- Will van Norel
Agenda
- Medication line: link with prescription and referral prescription
Minutes
- The business rules V.018FR have been shared, see issue 165, u fortunately only available in French
- there are some business experts meetings on ePrescription that will be conducted in April
- the document is not entirely complete
- please reveiw and add any need for clarification, questions, issues as comment to issue 165
- We would like to move forward to the publication of the medication line
- profile is here
- IG needs some clean-up
- recorded date & asserted date are not the same thing
- is it useful to know the asserted date in practice ?
- recorded date should not change when the resource is created, but this is lastupdateddate, so can we remove recorded date ? the WG agrees as the versioning is there and the lastUpdatedDate could be checked to find the recorded date
- subject & information source: Be profiles have to be used
- we look at the scheme on page 7 of the business rules V.018FR
- do we need a relationship between the medication line with the careplan, as set by the BIHR project
- we agree that this is not crucial for the publication so we move ahead ; however it needs to be added to the business rules
* Action items:
- review medication line will be presented to the FHIR validation group in order to move to publication
- review business rules
Next meeting: 16 April at 11AM
